Blood bank reagents
Ended Awarded Last action
- Contract number
- 36C25623F0067
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $108,917
Award facts
- Contract value 100% obligated
-
- $108,917.41 Current, with exercised options
- $109,315.39 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,342 | |
| Exercise an Option | $29,135 | |
| Funding Only Action | -$5,069 | |
| Exercise an Option | $29,533 | |
| Funding Only Action | -$2,404 | |
| Exercise an Option | $29,533 | |
| Original award | $29,533 |
About this award
Alba Bioscience, Inc., a Chicago-based supplier of blood bank reagents and in vitro diagnostic materials, was awarded a delivery order valued at $109,315.39 by Veterans Integrated Service Network 16 on November 1, 2022. The contract, which extends through October 31, 2026, is a firm fixed-price, non-set-aside award for blood bank reagents to support the Department of Veterans Affairs' healthcare operations. This delivery order falls under the parent GSA Schedule 65-VII (In Vitro Diagnostics, Reagents, and Tests), which enables VA medical facilities to efficiently procure specialized blood banking supplies and diagnostic testing materials. Alba Bioscience, a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., specializes in providing critical immunohematology products including antibody screening cells, blood typing reagents, and quality control kits essential for laboratory operations across federal healthcare systems.
This award represents one of Alba Bioscience's multiple delivery orders under existing Blanket Purchase Agreements with the Department of Veterans Affairs, reflecting the company's competitive standing as a specialized supplier of blood banking diagnostics. The company maintains two significant BPAs with the VA—one with VISN 15 (ceiling value $199,671.75 through May 31, 2030) and another with VISN 10 (ceiling value $109,420.35 through September 30, 2026)—both focused on blood bank and red blood cell reagents. Through these vehicles and individual delivery orders, Alba Bioscience supplies the diverse reagent and antibody products required to support the VA's integrated healthcare system's laboratory and transfusion medicine operations.
Quick answers
Who was awarded contract 36C25623F0067?
36C25623F0067 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 16 (Veterans Health Administration) on November 1, 2022.
How much is contract 36C25623F0067 worth?
The government has obligated $108,917 on 36C25623F0067. Its potential value, with all options, is $109,315.
Is contract 36C25623F0067 an order under another contract?
Yes. 36C25623F0067 is a delivery order under 36F79721D0259, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25623F0067 competed?
The extent of competition for 36C25623F0067 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award